+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Therapeutic Apheresis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Therapeutic Apheresis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Therapeutic Apheresis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 178 Pages
  • January 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 6050450
Description Jump to:
The global therapeutic apheresis market is set to experience substantial growth, driven by technological advancements and increasing demand for precision medicine. With a projected CAGR of 7.3%, the market is expected to reach USD 3.22 billion by 2025 and expand further to USD 5.30 billion by 2032.

Market Insights

Therapeutic apheresis is a specialized medical procedure used to selectively remove harmful components from the blood. It plays a crucial role in the treatment of autoimmune diseases, neurological disorders, and hematologic conditions. The increasing prevalence of these diseases, coupled with advancements in medical technology, is fueling the market's growth. The therapeutic apheresis market is poised for substantial growth, driven by continuous technological advancements, increasing disease prevalence, and a shift towards precision medicine. With major players investing in innovation and expanding applications, the market is set to witness significant transformation in the coming years.

Market Growth Drivers

  • Technological Innovations: The introduction of automated apheresis devices and membrane-based separation systems has enhanced precision, efficacy, and patient safety.
  • Rising Disease Prevalence: A growing incidence of autoimmune disorders and blood-related conditions is boosting demand for therapeutic apheresis procedures.
  • Aging Population: The expanding elderly demographic, which is more susceptible to conditions treatable with apheresis, contributes to market expansion.
  • Growing Awareness: Increasing recognition of apheresis as an effective treatment among healthcare professionals is driving adoption.

Business Opportunities

  • Integration with Precision Medicine: Therapeutic apheresis is gaining traction as an essential component of personalized treatment approaches.
  • Expanding Applications: Beyond traditional applications in hematology and neurology, apheresis is being explored for oncology and rare genetic disorders.
  • Strategic Collaborations: Partnerships among healthcare institutions, research organizations, and industry players are fostering technological advancements and market penetration.

Regional Analysis

  • North America: Expected to hold the largest market share due to advanced healthcare infrastructure, high healthcare expenditure, and strong technological innovation.
  • Asia Pacific: Forecasted to witness the highest growth rate, driven by increasing healthcare investments and rising awareness in countries like China and Japan.
  • Europe: A well-established healthcare system and regulatory support contribute to steady market expansion.
  • Latin America,, and the Middle East & Africa are also seeing increasing adoption due to rising healthcare needs and improving medical facilities.

Key Players

Leading companies are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their market presence. Notable players include:

  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Medica S.p.A.
  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation

Recent Developments

  • New Collaboration: Terumo Blood and Cell Technologies partnered with Eliaz Therapeutics to develop an innovative therapeutic apheresis solution for acute kidney injury (AKI).
  • Strategic Investment: NHS England approved Terumo’s Spectra Optia Apheresis System for treating sickle cell disease, significantly expanding its adoption.

Market Segmentation

By Procedure Type

  • Therapeutic Plasma Exchange (TPE)
  • Red Blood Cell Exchange (RBCX)
  • Cellular Depletions

By Technology

  • Centrifugation
  • Membrane Filtration

By Application

  • Hematology
  • Neurology
  • Nephrology
  • Rheumatology
  • Oncology
  • Others

By End User

  • Hospitals
  • Blood Banks
  • Specialty Clinics

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary
1.1. Global Therapeutic Apheresis Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2019 - 2023
3.1. Global Average Price Analysis by Procedure Type, 2019 - 2023
3.2. Prominent Factor Affecting Therapeutic Apheresis Prices
3.3. Global Average Price Analysis by Region
4. Global Therapeutic Apheresis Market Outlook, 2019 - 2032
4.1. Global Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Therapeutic Plasma Exchange (TPE)
4.1.1.2. Red Blood Cell Exchange (RBCX)
4.1.1.3. Cellular Depletions
4.2. Global Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Centrifugation
4.2.1.2. Membrane filtration
4.3. Global Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Hematology
4.3.1.2. Neurology
4.3.1.3. Nephrology
4.3.1.4. Rheumatology
4.3.1.5. Oncology
4.3.1.6. Others
4.4. Global Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Blood banks
4.4.1.3. Specialty clinics
4.5. Global Therapeutic Apheresis Market Outlook, by Region, Value (US$ Bn) and Volume (Box), 2019 - 2032
4.5.1. Key Highlights
4.5.1.1. North America
4.5.1.2. Europe
4.5.1.3. Asia Pacific
4.5.1.4. Latin America
4.5.1.5. Middle East & Africa
5. North America Therapeutic Apheresis Market Outlook, 2019 - 2032
5.1. North America sTherapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Therapeutic Plasma Exchange (TPE)
5.1.1.2. Red Blood Cell Exchange (RBCX)
5.1.1.3. Cellular Depletions
5.2. North America Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Centrifugation
5.2.1.2. Membrane filtration
5.3. North America Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Hematology
5.3.1.2. Neurology
5.3.1.3. Nephrology
5.3.1.4. Rheumatology
5.3.1.5. Oncology
5.3.1.6. Others
5.4. North America Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Blood banks
5.4.1.3. Specialty clinics
5.4.2. Attractiveness Analysis
5.5. North America Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.5.1. Key Highlights
5.5.1.1. U.S. Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.5.1.2. U.S. Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.5.1.3. U.S. Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.5.1.4. U.S. Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.5.1.5. Canada Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.5.1.6. Canada Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.5.1.7. Canada Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
5.5.1.8. Canada Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
6. Europe Therapeutic Apheresis Market Outlook, 2019 - 2032
6.1. Europe Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Therapeutic Plasma Exchange (TPE)
6.1.1.2. Red Blood Cell Exchange (RBCX)
6.1.1.3. Cellular Depletions
6.2. Europe Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Centrifugation
6.2.1.2. Membrane filtration
6.3. Europe Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Hematology
6.3.1.2. Neurology
6.3.1.3. Nephrology
6.3.1.4. Rheumatology
6.3.1.5. Oncology
6.3.1.6. Others
6.4. Europe Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Blood banks
6.4.1.3. Specialty clinics
6.4.2. Attractiveness Analysis
6.5. Europe Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1. Key Highlights
6.5.1.1. Germany Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.2. Germany Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.3. Germany Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.4. Germany Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.5. U.K. Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.6. U.K. Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.7. U.K. Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.8. U.K. Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.9. France Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.10. France Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.11. France Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.12. France Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.13. Italy Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.14. Italy Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.15. Italy Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.16. Italy Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.17. Turkey Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.18. Turkey Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.19. Turkey Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.20. Turkey Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.21. Russia Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.22. Russia Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.23. Russia Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.24. Russia Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.25. Rest of Europe Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.26. Rest of Europe Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.27. Rest of Europe Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
6.5.1.28. Rest of Europe Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
7. Asia Pacific Therapeutic Apheresis Market Outlook, 2019 - 2032
7.1. Asia Pacific Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Therapeutic Plasma Exchange (TPE)
7.1.1.2. Red Blood Cell Exchange (RBCX)
7.1.1.3. Cellular Depletions
7.2. Asia Pacific Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.2.1. Key Highlights
7.2.1.1. Centrifugation
7.2.1.2. Membrane filtration
7.3. Asia Pacific Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Hematology
7.3.1.2. Neurology
7.3.1.3. Nephrology
7.3.1.4. Rheumatology
7.3.1.5. Oncology
7.3.1.6. Others
7.4. Asia Pacific Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Blood banks
7.4.1.3. Specialty clinics
7.4.2. Attractiveness Analysis
7.5. Asia Pacific Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1. Key Highlights
7.5.1.1. China Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.2. China Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.3. China Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.4. China Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.5. Japan Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.6. Japan Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.7. Japan Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.8. Japan Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.9. South Korea Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.10. South Korea Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.11. South Korea Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.12. South Korea Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.13. India Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.14. India Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.15. India Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.16. India Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.17. Southeast Asia Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.18. Southeast Asia Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.19. Southeast Asia Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.20. Southeast Asia Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.21. Rest of Asia Pacific Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.22. Rest of Asia Pacific Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.23. Rest of Asia Pacific Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
7.5.1.24. Rest of Asia Pacific Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
8. Latin America Therapeutic Apheresis Market Outlook, 2019 - 2032
8.1. Latin America Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Therapeutic Plasma Exchange (TPE)
8.1.1.2. Red Blood Cell Exchange (RBCX)
8.1.1.3. Cellular Depletions
8.2. Latin America Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Centrifugation
8.2.1.2. Membrane filtration
8.3. Latin America Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Hematology
8.3.1.2. Neurology
8.3.1.3. Nephrology
8.3.1.4. Rheumatology
8.3.1.5. Oncology
8.3.1.6. Others
8.4. Latin America Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Blood banks
8.4.1.3. Specialty clinics
8.4.2. Attractiveness Analysis
8.5. Latin America Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1. Key Highlights
8.5.1.1. Brazil Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.2. Brazil Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.3. Brazil Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.4. Brazil Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.5. Mexico Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.6. Mexico Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.7. Mexico Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.8. Mexico Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.9. Argentina Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.10. Argentina Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.11. Argentina Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.12. Argentina Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.13. Rest of Latin America Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.14. Rest of Latin America Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.15. Rest of Latin America Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
8.5.1.16. Rest of Latin America Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
9. Middle East & Africa Therapeutic Apheresis Market Outlook, 2019 - 2032
9.1. Middle East & Africa Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.1.1. Key Highlights
9.1.1.1. Therapeutic Plasma Exchange (TPE)
9.1.1.2. Red Blood Cell Exchange (RBCX)
9.1.1.3. Cellular Depletions
9.2. Middle East & Africa Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.2.1. Key Highlights
9.2.1.1. Centrifugation
9.2.1.2. Membrane filtration
9.3. Middle East & Africa Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.3.1. Key Highlights
9.3.1.1. Hematology
9.3.1.2. Neurology
9.3.1.3. Nephrology
9.3.1.4. Rheumatology
9.3.1.5. Oncology
9.3.1.6. Others
9.4. Middle East & Africa Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Blood banks
9.4.1.3. Specialty clinics
9.4.2. Attractiveness Analysis
9.5. Middle East & Africa Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1. Key Highlights
9.5.1.1. GCC Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.2. GCC Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.3. GCC Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.4. GCC Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.5. South Africa Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.6. South Africa Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.7. South Africa Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.8. South Africa Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.9. Egypt Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.10. Egypt Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.11. Egypt Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.12. Egypt Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.13. Nigeria Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.14. Nigeria Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.15. Nigeria Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.16. Nigeria Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.17. Rest of Middle East & Africa Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.18. Rest of Middle East & Africa Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.19. Rest of Middle East & Africa Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
9.5.1.20. Rest of Middle East & Africa Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
10. Competitive Landscape
10.1. By Procedure Type vs by Technology Heatmap
10.2. Company Market Share Analysis, 2024
10.3. Competitive Dashboard
10.4. Company Profiles
10.4.1. Asahi Kasei Medical Co.
10.4.1.1. Company Overview
10.4.1.2. Product Portfolio
10.4.1.3. Financial Overview
10.4.1.4. Business Strategies and Development
10.4.2. Haemonetics Corporation
10.4.2.1. Company Overview
10.4.2.2. Product Portfolio
10.4.2.3. Financial Overview
10.4.2.4. Business Strategies and Development
10.4.3. Miltenyi Biotec
10.4.3.1. Company Overview
10.4.3.2. Product Portfolio
10.4.3.3. Financial Overview
10.4.3.4. Business Strategies and Development
10.4.4. Cerus Corporation
10.4.4.1. Company Overview
10.4.4.2. Product Portfolio
10.4.4.3. Financial Overview
10.4.4.4. Business Strategies and Development
10.4.5. Terumo BCT Inc.
10.4.5.1. Company Overview
10.4.5.2. Product Portfolio
10.4.5.3. Financial Overview
10.4.5.4. Business Strategies and Development
10.4.6. Fresenius Kabi USA
10.4.6.1. Company Overview
10.4.6.2. Product Portfolio
10.4.6.3. Financial Overview
10.4.6.4. Business Strategies and Development
10.4.7. Terumo BCT
10.4.7.1. Company Overview
10.4.7.2. Product Portfolio
10.4.7.3. Financial Overview
10.4.7.4. Business Strategies and Development
10.4.8. B. Braun Melsungen AG
10.4.8.1. Company Overview
10.4.8.2. Product Portfolio
10.4.8.3. Financial Overview
10.4.8.4. Business Strategies and Development
10.4.9. Nikkiso Co. Ltd.
10.4.9.1. Company Overview
10.4.9.2. Product Portfolio
10.4.9.3. Financial Overview
10.4.9.4. Business Strategies and Development
10.4.10. Medica S.p.A.
10.4.10.1. Company Overview
10.4.10.2. Product Portfolio
10.4.10.3. Financial Overview
10.4.10.4. Business Strategies and Development
10.4.11. Baxter Healthcare Corporation
10.4.11.1. Company Overview
10.4.11.2. Product Portfolio
10.4.11.3. Financial Overview
10.4.11.4. Business Strategies and Development
10.4.12. Kawasumi Laboratories Inc.
10.4.12.1. Company Overview
10.4.12.2. Product Portfolio
10.4.12.3. Financial Overview
10.4.12.4. Business Strategies and Development
10.4.13. Therakos Incorporation
10.4.13.1. Company Overview
10.4.13.2. Product Portfolio
10.4.13.3. Financial Overview
10.4.13.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • Terumo BCT
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Medica S.p.A.
  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Apheresis Market Report by Component, Product, Technology, Procedure, Application, End User, and Region 2024-2032 - Product Image

Apheresis Market Report by Component, Product, Technology, Procedure, Application, End User, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Apheresis Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Apheresis Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 156 Pages
  • Global
From
Apheresis Consumables And Equipment Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Apheresis Consumables And Equipment Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 154 Pages
  • Global
From
Apheresis Equipment - Global Strategic Business Report - Product Image

Apheresis Equipment - Global Strategic Business Report

  • Report
  • 604 Pages
  • Global
From
Apheresis Market Size by Product (Device (Centrifugation, Membrane Separation) Disposable), Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), and Region - Forecast to 2029 - Product Image

Apheresis Market Size by Product (Device (Centrifugation, Membrane Separation) Disposable), Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), and Region - Forecast to 2029

  • Report
  • 330 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.